Sponsor: 
GlaxoSmithKline Australia
Administration route: 
Intramuscular injection
Vaccine group: 
All people aged ≥6 months

Registered for use in people aged ≥6 months.

Quadrivalent inactivated influenza vaccine

Each 0.5 mL monodose pre-filled syringe contains:

  • 15 µg haemagglutinin of each of the 4 recommended influenza virus strains
  • ≤0.05 µg ovalbumin
  • ≤5 µg formaldehyde
  • polysorbate 80
  • octoxinol 10

May contain traces of:

  • gentamicin
  • hydrocortisone
  • sodium deoxycholate

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
23 April 2019
Last reviewed: 
23 April 2019